KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Receivables (2016 - 2025)

Cvs Health's Receivables history spans 17 years, with the latest figure at $50.3 billion for Q4 2025.

  • For the quarter ending Q4 2025, Receivables rose 8.61% year-over-year to $50.3 billion, compared with a TTM value of $50.3 billion through Dec 2025, up 8.61%, and an annual FY2025 reading of $50.3 billion, up 8.61% over the prior year.
  • Receivables for Q4 2025 was $50.3 billion at Cvs Health, down from $55.1 billion in the prior quarter.
  • The five-year high for Receivables was $55.1 billion in Q3 2025, with the low at $11.7 billion in Q4 2022.
  • Average Receivables over 5 years is $31.7 billion, with a median of $33.0 billion recorded in 2021.
  • Year-over-year, Receivables crashed 63.97% in 2022 and then soared 304.28% in 2023.
  • Tracing CVS's Receivables over 5 years: stood at $32.4 billion in 2021, then crashed by 63.97% to $11.7 billion in 2022, then soared by 304.28% to $47.1 billion in 2023, then dropped by 1.67% to $46.4 billion in 2024, then rose by 8.61% to $50.3 billion in 2025.
  • Per Business Quant, the three most recent readings for CVS's Receivables are $50.3 billion (Q4 2025), $55.1 billion (Q3 2025), and $51.1 billion (Q2 2025).